Study strengthens concerns about long-term use of certain painkillers

July 22, 2011, University of Florida

(Medical Xpress) -- Painkillers such as ibuprofen, naxopren and celecoxib provide needed relief for many patients who have chronic pain. But an ongoing source of contention is whether those drugs and others in their class known as nonsteroidal anti-inflammatory drugs, or NSAIDs, are linked to harmful health effects.

Now a new study from the University of Florida raises the concern about potential risks to a higher degree than before, finding a doubling of deaths from heart attack, and related events among people who have both hypertension and and use the drugs long term.

The findings, based on data from the international INVEST clinical study of therapies, are published in the current issue of The .

“It does strengthen our practice recommendations,” said lead author Dr. Anthony A. Bavry, an assistant professor of cardiovascular medicine in the UF College of Medicine’s department of medicine.

Physicians already discourage the use of NSAIDs among the elderly and after heart attacks, on the basis of several studies showing that the drugs are linked with a higher risk of stroke and heart attack.

But the UF researchers, including senior author Dr. Carl J. Pepine, a professor of cardiovascular medicine in the UF College of Medicine, advise patients to talk to their doctors before stopping use of prescribed treatments.

“It’s a tricky issue, because NSAIDs are useful for relieving pain, and that is much of what we do in medicine — alleviate pain and suffering,” said Dr. Deepak L. Bhatt, an associate professor of medicine at Harvard Medical School and chief of cardiology at the VA Boston Healthcare System, who recently published findings that NSAIDs are linked to a higher risk of stroke. “Unfortunately, most medications have some potential side effects, and it’s important to know what those might be.” Bhatt was not involved in the UF study.

Patients who have both high blood pressure and coronary artery disease are generally put on aspirin, a unique type of NSAID, to reduce their risk of a heart attack. Physicians are concerned that giving those patients other NSAIDs for pain relief could cancel out aspirin’s beneficial effects and raise the risk of negative cardiovascular effects.

The UF research team took advantage of the availability of INVEST study data from 882 chronic NSAID users and almost 22,000 intermittent or nonusers to try to settle the question. They looked at patients who reported using NSAIDs over an average of about three years, to see whether there was an increase in adverse events or cardiovascular-related compared with patients who did not use those pain medicines long term.

The risk of death from cardiovascular causes was 2.3 times higher among patients who chronically used the drugs than among other patients.

NSAIDs are thought to act in a variety of ways to increase cardiovascular risk. They are thought to prevent aspirin’s protective anti-clotting effect by preventing the aspirin from binding properly to platelets in the blood. Some NSAIDs might also increase bleeding risk. In addition, NSAIDs raise blood pressure, thus potentially raising the risk of heart attack and stroke. Some NSAIDs have already been removed from the market because of concerns about an elevated risk of and stroke.

While randomized clinical trials are still needed to definitively show a link between NSAIDS and cardiovascular effects, the current study is only the latest in a growing body of research that strongly suggests an association.

“There have been enough studies now that it certainly raises suspicion,” Bhatt said. “The question that’s still open is, is it all NSAIDs, or are some worse than others?”

The UF study did not compare specific NSAIDs, so more research has to be carried out to determine the level of risk that might be associated with each.

The INVEST study was funded by Abbott Laboratories and the University of Florida Opportunity Fund. The National Institutes of Health also provided grant support for several of the researchers. Members of the research team have also received grant funding from, or served as consultants for, a number of pharmaceutical companies.

Explore further: Long-term NSAID use by hypertensive patients with CAD increases risk of adverse events

Related Stories

Long-term NSAID use by hypertensive patients with CAD increases risk of adverse events

July 13, 2011
A study published in the July issue of The American Journal of Medicine, reports that among hypertensive patients with coronary artery disease, chronic self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs) was ...

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
not rated yet Jul 22, 2011
Disturbing research.

It raises the question, should aspirin continue to be prescribed/used to reduce the incidence of vascular events?

Is aspirin OK, or should it be avoided?

Hope there is further research to address this.
ziphead
not rated yet Jul 26, 2011
Disturbing research.

It raises the question, should aspirin continue to be prescribed/used to reduce the incidence of vascular events?

Is aspirin OK, or should it be avoided?

Hope there is further research to address this.


Breath in. Then out.
1. This is a long known issue with COX-2 selective NSAIDs.
2. Aspirin is not one of those.
3. And don't worry, there will be way more research about this, only not the kind that looks at natural alternatives. Like boswellic acid, for instance.
dogbert
not rated yet Jul 26, 2011
The study was not about the COX-2 selective NSAIDs. It was about NSAIDs in general.

I think that only one COX-2 selective NSAID remains available and it has little use.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.